Two out of three patients with major depression do not correctly follow the treatment prescribed by their doctor

This year, World Health Day, which is to be celebrated on Friday, has been dedicated to depression

Medical, technological and legal progresses boost R&D of new medicines to fight rare diseases

World Rare Diseases Day is commemorated tomorrow

Spain, above the European average in clinical trials in oncology

The excellence of the professionals, the quality of the National Health System, the commitment of the industry and the new legal framework, facilitate the clinical research against cancer in Spain

The improvement of the medicines ensures that the healthcare cost of the cancer treatment remains stable despite the increase in the incidence rates

European Commission Initiative Improves Information for Patients on Biosimilar Medicines

Download document

The II Somos Pacientes (‘We Are Patients’) Awards recognized the best initiatives developed for the benefit of patients

The Farmaindustria Foundation increased the awards that it grants to six, and presented them in a ceremony last Tuesday in Madrid.

Farmaindustria respects the ruling on tenders in Andalusia, but highlights the negative consequences they may generate

It proposes a national and long term vision as far as pharmaceutical policy is concerned.

Administrations, healthcare professionals and associations seek to boost the role of the patient in the life cycle of the drug.

The President of Farmaindustria underlines the importance of listening to patients, so that they can be at the centre of healthcare systems.

Healthcare professionals, patients and industry present a plan to improve adherence to treatment

Technical proposal to health authorities to combat the high rate of therapeutic non-compliance and its effects on health

The new Royal Decree Law allows for a 19% time reduction when starting a new clinical trial in Spain, just six months after coming into force

Farmaindustria publishes updated data from the BEST project (June 30th) demonstrating the positive effect of this legislation

EFPIA Statement on the UN HLP Report on Access to Medicines

Download document

© 2022 FarmaIndustria All rights reserved